Patent details

Herbas

VPB

Print

EN | LT

LT - COMBINATION OF CERITINIB WITH AN EGFR INHIBITOR

EN - COMBINATION OF CERITINIB WITH AN EGFR INHIBITOR

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	A61K 31/4709
		A61K 31/506
		A61K 31/517
		A61K 31/5377
		C07K 16/32
		A61K 39/395
		A61K 45/06
		A61P 35/00
		A61K 31/519
		A61K 31/55
		A61K 31/4706

European patent
(11)	Number of the document	3206717
(13)	Kind of document	T
(96)	European patent application number	15784975.3
	Date of filing the European patent application	2015-10-15
(97)	Date of publication of the European application	2017-08-23
(45)	Date of publication and mention of the grant of the patent	2020-11-25
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/IB2015/057940
	Date	2015-10-15

PCT application publication
(87)	Number	WO 2016/059600
	Date	2016-04-21

Priority applications
(30)	Number	Date	Country code
	201462065451 P	2014-10-17	US
	201462068175 P	2014-10-24	US
	201462068945 P	2014-10-27	US
	201562118710 P	2015-02-20	US

Inventors
(72)	BORAL, Anthony, US LI, Fang, US LI, Nanxin, US PANTANO, Serafino, CH

Grantee
(73)	Novartis AG, Lichtstrasse 35, 4056 Basel, CH

Title
(54)	COMBINATION OF CERITINIB WITH AN EGFR INHIBITOR
	COMBINATION OF CERITINIB WITH AN EGFR INHIBITOR